Surgical Quality Improvement

Total Hip Arthroplasty Outcomes

Total Hip Arthroplasty ACS NSQIP Outcomes

January 1, 2020 – December 31, 2020

The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall total hip arthroplasty ACS NSQIP performance benchmarked against 490 participating sites.

Total Hip Arthroplasty (490 sites)NObservedExpected
30 Day Mortality3370.59%0.69%
30 Day Morbidity3375.04%4.48%
Cardiac 3371.19%0.45%
Pneumonia3370.89%0.45%
Deep Vein Thrombosis (DVT) / Pulmonary Embolus3370.30%0.77%
Renal Failure3370.30%0.26%
Urinary Tract Infection (UTI)3370.89%0.65%
Surgical Site Infection (SSI)3361.19%1.88%
Sepsis3371.48%0.39%
Return to Operating Room (ROR)3373.86%3.12%
Readmission 3378.31%5.32%

American College of Surgeons National Surgical Quality Improvement Program, 2021.
ACS NSQIP® Semiannual Report July 8, 2021, Chicago: American College of Surgeons.